ALLcrimesfood&drugstaxestelecomcommercehealthconservationtransportationagricultureveteransbrowse all titles »
0

42 U.S.C. § 285l–3Interagency Coordinating Committee on the Validation of Alternative Methods

submitted 26 years ago by Pub. L. 106-545 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 915 words · no verdicts yet

in plain englishAI-generated · not legal advice

This section makes ICCVAM a permanent committee that reviews animal-testing alternatives. It's made up of agency heads and advised by a scientific committee. ICCVAM reviews test methods, coordinates agencies, and reports results to the public.

(a) In general: This section makes the Interagency Coordinating Committee on the Validation of Alternative Methods ("ICCVAM") — a committee the Director of the National Institute of Environmental Health Sciences already created — into a permanent interagency committee. It sits inside the Institute's National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. This section does not change the Director's existing authority over ICCVAM from before December 19, 2000, except where this section conflicts with that authority. (b) Purposes: ICCVAM exists to (1) make federal agencies' review of test methods more efficient and effective; (2) stop agencies from duplicating each other's work, and get them sharing what they learn; (3) make the best use of scientific expertise found outside the federal government; (4) make sure new or revised test methods are proven valid before agencies need them; and (5) reduce, refine, or replace the use of animals in testing wherever that's possible. (c) Composition: ICCVAM is made up of the heads (or their designees) of these federal agencies: the Agency for Toxic Substances and Disease Registry, the Consumer Product Safety Commission, the Department of Agriculture, the Department of Defense, the Department of Energy, the Department of the Interior, the Department of Transportation, the Environmental Protection Agency, the Food and Drug Administration, the National Institute for Occupational Safety and Health, the National Institutes of Health, the National Cancer Institute, the National Institute of Environmental Health Sciences, the National Library of Medicine, the Occupational Safety and Health Administration, and any other agency that develops or uses animal tests or test data, or regulates based on animal toxicity testing. (d) Scientific Advisory Committee: (1) The Director of the National Institute of Environmental Health Sciences must create a Scientific Advisory Committee ("SAC") to advise ICCVAM and the Center on ICCVAM's work. The SAC must follow the federal advisory-committee rules in title 5, chapter 10. (2) Membership: The SAC's voting members must include at least one expert in new, revised, or alternative test methods from each of: the personal care, pharmaceutical, industrial chemicals, or agriculture industry; any other industry regulated by the agencies listed in subsection (c); and a national animal-protection organization set up under section 501(c)(3) of the tax code. It must also include representatives — chosen by the Director — from an academic institution, a state government agency, an international regulatory body, or a company that develops or sells alternative test methods, including contract labs. In addition, the agency heads named in subsection (c) (or their designees) serve as nonvoting members. (e) Duties: ICCVAM must (1) review and evaluate new, revised, or alternative test methods — including groups of tests — and coordinate technical reviews across agencies; (2) help agencies and countries align their toxicological test rules in ways that encourage reducing, refining, or replacing animal tests; (3) give guidance on how to set validation standards and run validation studies, and help get validated methods accepted and known; (4) send its official test recommendations, through the Secretary of Health and Human Services, to each relevant federal agency, along with notes on which of that agency's guidelines or rules the recommendation could improve; (5) consider petitions from the public that point to a specific rule and propose a new or alternative test method backed by real scientific evidence; (6) make its final test recommendations public, along with each agency's response to them; and (7) publish progress reports — the first one within 12 months of December 19, 2000, and then every two years after that.
the actual law source: uscode.house.gov ↗public domain
(a) In general

With respect to the interagency coordinating committee that is known as the Interagency Coordinating Committee on the Validation of Alternative Methods (referred to in sections 285l–2 to 285l–5 of this title as “ICCVAM”) and that was established by the Director of the National Institute of Environmental Health Sciences for purposes of section 285l–1(b) of this title, the Director of the Institute shall designate such committee as a permanent interagency coordinating committee of the Institute under the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Sections 285l–2 to 285l–5 of this title may not be construed as affecting the authorities of such Director regarding ICCVAM that were in effect on the day before December 19, 2000, except to the extent inconsistent with sections 285l–2 to 285l–5 of this title.

(b) Purposes

The purposes of the ICCVAM shall be to—

(1)

increase the efficiency and effectiveness of Federal agency test method review;

(2)

eliminate unnecessary duplicative efforts and share experiences between Federal regulatory agencies;

(3)

optimize utilization of scientific expertise outside the Federal Government;

(4)

ensure that new and revised test methods are validated to meet the needs of Federal agencies; and

(5)

reduce, refine, or replace the use of animals in testing, where feasible.

(c) Composition

The ICCVAM shall be composed of the heads of the following Federal agencies (or their designees):

(1)

Agency for Toxic Substances and Disease Registry.

(2)

Consumer Product Safety Commission.

(3)

Department of Agriculture.

(4)

Department of Defense.

(5)

Department of Energy.

(6)

Department of the Interior.

(7)

Department of Transportation.

(8)

Environmental Protection Agency.

(9)

Food and Drug Administration.

(10)

National Institute for Occupational Safety and Health.

(11)

National Institutes of Health.

(12)

National Cancer Institute.

(13)

National Institute of Environmental Health Sciences.

(14)

National Library of Medicine.

(15)

Occupational Safety and Health Administration.

(16)

Any other agency that develops, or employs tests or test data using animals, or regulates on the basis of the use of animals in toxicity testing.

(d) Scientific Advisory Committee
(1) Establishment

The Director of the National Institute of Environmental Health Sciences shall establish a Scientific Advisory Committee (referred to in sections 285l–2 to 285l–5 of this title as the “SAC”) to advise ICCVAM and the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods regarding ICCVAM activities. The activities of the SAC shall be subject to provisions of chapter 10 of title 5.

(2) Membership
(A) In general

The SAC shall be composed of the following voting members:

(i)

At least one knowledgeable representative having a history of expertise, development, or evaluation of new or revised or alternative test methods from each of—

(I)

the personal care, pharmaceutical, industrial chemicals, or agriculture industry;

(II)

any other industry that is regulated by the Federal agencies specified in subsection (c); and

(III)

a national animal protection organization established under section 501(c)(3) of title 26.

(ii)

Representatives (selected by the Director of the National Institute of Environmental Health Sciences) from an academic institution, a State government agency, an international regulatory body, or any corporation developing or marketing new or revised or alternative test methodologies, including contract laboratories.

(B) Nonvoting ex officio members

The membership of the SAC shall, in addition to voting members under subparagraph (A), include as nonvoting ex officio members the agency heads specified in subsection (c) (or their designees).

(e) Duties

The ICCVAM shall, consistent with the purposes described in subsection (b), carry out the following functions:

(1)

Review and evaluate new or revised or alternative test methods, including batteries of tests and test screens, that may be acceptable for specific regulatory uses, including the coordination of technical reviews of proposed new or revised or alternative test methods of interagency interest.

(2)

Facilitate appropriate interagency and international harmonization of acute or chronic toxicological test protocols that encourage the reduction, refinement, or replacement of animal test methods.

(3)

Facilitate and provide guidance on the development of validation criteria, validation studies and processes for new or revised or alternative test methods and help facilitate the acceptance of such scientifically valid test methods and awareness of accepted test methods by Federal agencies and other stakeholders.

(4)

Submit ICCVAM test recommendations for the test method reviewed by the ICCVAM, through expeditious transmittal by the Secretary of Health and Human Services (or the designee of the Secretary), to each appropriate Federal agency, along with the identification of specific agency guidelines, recommendations, or regulations for a test method, including batteries of tests and test screens, for chemicals or class of chemicals within a regulatory framework that may be appropriate for scientific improvement, while seeking to reduce, refine, or replace animal test methods.

(5)

Consider for review and evaluation, petitions received from the public that—

(A)

identify a specific regulation, recommendation, or guideline regarding a regulatory mandate; and

(B)

recommend new or revised or alternative test methods and provide valid scientific evidence of the potential of the test method.

(6)

Make available to the public final ICCVAM test recommendations to appropriate Federal agencies and the responses from the agencies regarding such recommendations.

(7)

Prepare reports to be made available to the public on its progress under sections 285l–2 to 285l–5 of this title. The first report shall be completed not later than 12 months after December 19, 2000, and subsequent reports shall be completed biennially thereafter.

Source credit: (Pub. L. 106–545, § 3, Dec. 19, 2000, 114 Stat. 2721; Pub. L. 117–286, § 4(a)(235), Dec. 27, 2022, 136 Stat. 4331.)

history & why it existsrecord from the source credit
  • 2000Enacted · Pub. L. 106-545 · 114 Stat. 2721
  • 2022Amended · Pub. L. 117-286 · 136 Stat. 4331

A history note hasn’t been published yet. The record shows enactment by Pub. L. 106-545 on 2000-12-19.

all 0 arguments · sorted by: best

0/280

no arguments yet — make the first case